Counterfeit Medication, R&D Financing Key IP Issues At WHO Board Meeting
By Kaitlin Mara The Executive Board of the World Health Organization meets next week with significant discussion expected on a new secretariat report on counterfeit medical products as well as on the implementation of the WHO’s mandated global strategy on…
